INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jefferies Financial Group Inc. - JEF — Neutral
JEF GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Jefferies Financial Group Inc. (“Jefferies” or the “Company”) (NYSE: JEF). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD — Neutral
WALD GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Venu Holding Corporation - VENU — Neutral
VENU GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Venu Holding Corporation (“Venu” or the “Company”) (NYSE: VENU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caledonia Mining Corporation Plc - CMCL — Neutral
CMCL GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Caledonia Mining Corporation Plc (“Caledonia Mining” or the “Company”) (NYSE: CMCL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
EL's North America Trends Improve but Asia Remains the Wild Card — Neutral
EL Zacks Investment Research — January 06, 2026Estee Lauder shows signs of North America stabilization as declines ease, but uneven Asia demand and volatile travel retail keep the regional balance in question.
Celestica Stock Rises 21.6% in Three Months: Should You Invest? — Positive
CLS Zacks Investment Research — January 06, 2026CLS shares are up 21.6% in three months as AI data center demand boosts networking sales, but premium valuation and customer concentration risks remain.
Citigroup Stock Reaches New 52-Week High: Hold or Fold Now? — Positive
C Zacks Investment Research — January 06, 2026C hits a new 52-week high as strategic exits, easing regulation and a softer-rate backdrop lift confidence, but is there more upside left? Let us find out.
Can S&P 500 Sustain Double-Digit Winning Streak in 2026? ETFs in Focus — Neutral
GLD SMH XLK Zacks Investment Research — January 06, 2026Can the S&P 500 extend its double-digit run in 2026? Valuations, Fed shifts, AI risks loom as ETFs like SPY, XLK, GLD take focus.
2 Auto Retailers Poised to Outperform in a Shifting 2026 Landscape — Positive
ABG AN Zacks Investment Research — January 06, 2026With the Zacks Auto Retail industry ranked favorably, stocks like AN and ABG are worth investing in.
Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026? — Positive
BBC ILIT LITP SBIO SIVR SLV Zacks Investment Research — January 06, 2026Wall Street put up a modest show in the final quarter of 2025, with the S&P 500 advancing only 1.9%, the Dow Jones gaining 3.3% and the Nasdaq Composite adding about 2.1%. The small-cap index Russell 2000 added 1.6% during that period.
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman — Neutral
CORT PRNewsWire — January 06, 2026SAN FRANCISCO, Jan. 6, 2026 /PRNewswire/ -- Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter ("CRL") from the FDA for its proposed treatment of patients with hypercortisolism (also known as Cushing's syndrome) – relacorilant. The news and severe market reaction has prompted national shareholder rights law firm Hagens Berman to commence an investigation into whether Corcept may have misled investors about relacorilant's efficacy and commercial prospects.
Hormel Foods trades near 52-week lows with a forward P/E of 15.7 and an attractive 5.1% dividend yield. HRL demonstrates resilient organic growth across all segments, supported by strong brands and ongoing portfolio modernization. Management guides for 1%–4% organic sales growth and 7% operating income growth midpoint in fiscal 2026 as margin pressures ease.
Allison Worldwide and Stagwell (STGW) Bolster Communications and Healthcare Capabilities in Naming Wendy Lund as Global CEO, Allison and Stagwell's Vice Chair of Health — Neutral
STGW Accesswire — January 06, 2026NEW YORK CITY, NEW YORK / ACCESS Newswire / January 6, 2026 / Allison Worldwide and Stagwell (NASDAQ: STGW ) are turbocharging their global communications capabilities and positioning for growth in healthcare with the appointment of industry veteran Wendy Lund as Global Chief Executive Officer, Allison Worldwide and Stagwell's new Vice Chair of Health. Joining Jan. 12, Lund brings more than three decades of expertise and visionary leadership to the dual role.
NXP Advances Edge AI Leadership with New eIQ Agentic AI Framework — Neutral
NXPI GlobeNewsWire — January 06, 2026NXP announced its new eIQ Agentic AI Framework, a trusted foundation to rapidly prototype and deploy optimized, secure, autonomous AI systems at the edge.
NBCUniversal, RPA, FreeWheel, and Newton Research Introduce Agentic AI Buying Across Linear and Digital for Premium Video — Neutral
CMCSA Business Wire — January 06, 2026NEW YORK--(BUSINESS WIRE)--Today NBCUniversal, independent agency RPA, FreeWheel, and Newton Research announced a partnership to introduce a breakthrough approach to buying premium video using agentic AI across both linear and digital. In a first-of-its-kind proof-of-concept, an agency can execute and optimize a single premium video investment across platforms in seconds, as illustrated in the video demo here. Newton, NBCUniversal, and FreeWheel's agents orchestrate cross-platform video buying.
IMDb Announces the Most Anticipated Movies and Series of 2026 — Neutral
AMZN Business Wire — January 06, 2026SEATTLE--(BUSINESS WIRE)--IMDb (www.imdb.com), the world's most popular and authoritative source for information on movies, TV shows, and celebrities, today unveiled the most anticipated movies and new series of 2026. Rather than base its annual rankings on small statistical samplings, IMDb determines its list of the most anticipated titles by the actual page views of the more than 250 million monthly visitors to IMDb. This exclusive and definitive data is derived from the IMDbPro MOVIEmeter ra.
PRMB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Primo Brands Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
PRMB GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Primo Brands Corporation (“Primo” or “the Company”) (NYSE: PRMB; PRMW) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired (i) the publicly traded common stock of Primo Water Corporation (“Primo Water”) between June 17, 2024 through November 8, 2024, inclusive, and/or (ii) the publicly traded common …
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
AGL GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain of its officers.
Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
KLAR GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Klarna Group plc (NYSE: KLAR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Klarna securities pursuant to the registration statement and prospectus issued in connection with the Company's September 10, 2025 initial public offering ("IPO").
Bronstein, Gewirtz & Grossman LLC Urges Stride, Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
LRN GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Stride securities between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”).